Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herba Desmodii Styracifolii Flavonoids Capsule after ureteroscopic treatment of kidney stones
ChiCTR2400089687Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of herba desmodii styracifolii flavonoids capsule in nephrolithiasis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Stone free rate on the 14th day after surgery. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
herba desmodii styracifolii flavonoids capsule
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on ChiCTR2400089687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089687.